IT1244647B - Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo. - Google Patents
Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo.Info
- Publication number
- IT1244647B IT1244647B ITRM910085A ITRM910085A IT1244647B IT 1244647 B IT1244647 B IT 1244647B IT RM910085 A ITRM910085 A IT RM910085A IT RM910085 A ITRM910085 A IT RM910085A IT 1244647 B IT1244647 B IT 1244647B
- Authority
- IT
- Italy
- Prior art keywords
- quercitin
- cancer therapy
- ovarian
- pharmaceutical product
- active principle
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
- C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Si descrive un prodotto, utilizzabile nella terapia dei tumori, contenente almeno una delle seguenti sostanze:sale della quercitina con lo zinco,sale della quercitina col selenio,composto fluorurato della quercitina,composto glicosidico della quercitina.Tale prodotto è caratterizzato da un tempo di permanenza nell'organismo, e quindi da un'efficacia terapeutica, maggiore di quello della quercitina non legata.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM910085A IT1244647B (it) | 1991-02-05 | 1991-02-05 | Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo. |
EP92905230A EP0570475A1 (en) | 1991-02-05 | 1992-01-31 | Pharmaceutical preparation for the therapy of tumors, particularly ovarian and haemopoietic system tumors, containing quercetin compounds as active substances |
JP4505072A JPH07502009A (ja) | 1991-02-05 | 1992-01-31 | クエルセチン化合物を活性物質として含有する腫瘍、特に卵巣及び造血系の腫瘍の治療用薬剤 |
PCT/IT1992/000007 WO1992013851A1 (en) | 1991-02-05 | 1992-01-31 | Pharmaceutical product for the therapy of tumors, particularly ovarian and haemopoietic system tumors, containing quercetin compounds as active substances |
AU12691/92A AU1269192A (en) | 1991-02-05 | 1992-01-31 | Pharmaceutical product for the therapy of tumors, particularly ovarian and haemopoietic system tumors, containing quercetin compounds as active substances |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM910085A IT1244647B (it) | 1991-02-05 | 1991-02-05 | Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo. |
Publications (3)
Publication Number | Publication Date |
---|---|
ITRM910085A0 ITRM910085A0 (it) | 1991-02-05 |
ITRM910085A1 ITRM910085A1 (it) | 1992-08-05 |
IT1244647B true IT1244647B (it) | 1994-08-08 |
Family
ID=11399834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITRM910085A IT1244647B (it) | 1991-02-05 | 1991-02-05 | Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0570475A1 (it) |
JP (1) | JPH07502009A (it) |
AU (1) | AU1269192A (it) |
IT (1) | IT1244647B (it) |
WO (1) | WO1992013851A1 (it) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITRM20010600A1 (it) * | 2001-10-04 | 2003-04-04 | Brane Tech S R L | Composti flavonoidici capaci di modificare lo stato fisico e/o dinamico di membrane biologiche e di stimolare la sintesi endogena di protein |
EA026964B1 (ru) * | 2010-11-24 | 2017-06-30 | Дьюрект Корпорейшн | Биоразлагаемая композиция для доставки лекарственного средства (варианты) |
WO2014082027A2 (en) | 2012-11-26 | 2014-05-30 | Access Business Group International Llc | Antioxidant dietary supplement and related method |
CN111068095B (zh) * | 2020-02-07 | 2021-07-13 | 中国科学院上海硅酸盐研究所 | 高效诱导烧伤创面毛囊再生的生物活性离子改性槲皮素螯合剂组合物及其制备方法和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2892845A (en) * | 1957-11-26 | 1959-06-30 | Jurd Leonard | Selective etherification of the 7-hydroxyl group in polyhydroxy flavonoids |
FR3541M (fr) * | 1964-05-12 | 1965-09-13 | Laroche Navarron Lab | Médicament a propriétés natriurétiques a base d'une nouvelle flavone. |
-
1991
- 1991-02-05 IT ITRM910085A patent/IT1244647B/it active IP Right Grant
-
1992
- 1992-01-31 AU AU12691/92A patent/AU1269192A/en not_active Abandoned
- 1992-01-31 EP EP92905230A patent/EP0570475A1/en not_active Withdrawn
- 1992-01-31 JP JP4505072A patent/JPH07502009A/ja active Pending
- 1992-01-31 WO PCT/IT1992/000007 patent/WO1992013851A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1992013851A1 (en) | 1992-08-20 |
AU1269192A (en) | 1992-09-07 |
JPH07502009A (ja) | 1995-03-02 |
EP0570475A1 (en) | 1993-11-24 |
ITRM910085A1 (it) | 1992-08-05 |
ITRM910085A0 (it) | 1991-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY111791A (en) | Aqueous gel retinoid dosage form. | |
RU94041223A (ru) | Средство для лечения мотонейроновых заболеваний | |
BG101118A (en) | Therapeutical compounds | |
KR940018089A (ko) | 내부조직의 방사선 손상에 대한 예방 및 처치방법 | |
DE60143911D1 (de) | Antitumorzusammensetzungen welche ecteinascidin 743 enthalten | |
CO4910145A1 (es) | Uso | |
DK0583421T3 (da) | Substituerede dibenzoxazepinforbindelser, lægemidler og fremgangsmåder til anvendelse | |
AU1206292A (en) | Therapeutic agents for the treatment of multidrug resistance to cancers | |
IT1247509B (it) | Composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus | |
IT1244647B (it) | Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo. | |
IT1254995B (it) | Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani | |
MX9203361A (es) | Composiciones farmaceuticas que contienen cloruro de galio. | |
TR200100611T2 (tr) | İbuprofen ve domperidon içeren farmasötik kompozisyonlar | |
ITRM910730A1 (it) | Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali. | |
ITMI932189A1 (it) | Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta | |
IT1241079B (it) | Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico | |
ES2031462T3 (es) | Procedimiento para producir 1-b-d-arabinofuranosilcitosina-5'-estearilfosfato monosodico y monohidrato de la misma, y compuesto farmaceutico que contiene esta ultima. | |
ATE293445T1 (de) | Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel | |
ITRM910155A0 (it) | Preparati farmaceutici per la terapia dei tumori contenenti colchicina come principio attivo e metodi per l'impiego degli stessi. | |
KR930702016A (ko) | 골다공증 치료제 | |
KR880008807A (ko) | 정신병의 치료방법 | |
RU94033096A (ru) | Соединение, способ лечения и фармацевтическая композиция | |
ES2094734T3 (es) | Derivados de cefalosporinas y procedimiento para su preparacion. | |
RU95102013A (ru) | Способ лечения похмельного синдрома при алкоголизме | |
UA19504A (uk) | Засіб для лікуваhhя гhійhих запалеhь шкіри та підшкірhої клітковиhи |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19960215 |